TipRanks
Go Ultimate55% OFF

Mayne Pharma Group (HG6) Balance Sheet

Mayne Pharma Group Balance Sheet

Mayne Pharma Group's total assets for Q4 2026 were $909.45M, a decrease of 3.31% from the previous quarter. DE:HG6 total liabilities were $518.50M for the fiscal quarter, a 11.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetJun 26Jun 25Jun 24Jun 23Jun 22
$ 909.45M$ 1.01B$ 1.14B$ 1.25B$ 1.30B
$ 518.50M$ 644.32M$ 688.99M$ 613.77M$ 764.89M
$ 390.94M$ 370.28M$ 454.19M$ 634.36M$ 538.23M

Currency in AUD

Mayne Pharma Group Debt to Assets

0800M1.6B2.4B20 %40 %60 %80 %LiabilitiesDebt to Assets2017201820192020202120222023202420252026AssetsLiabilitiesDebt to Assets